FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial

Not Applicable

Not yet recruiting

Conditions: Lung Non-Small Cell Carcinoma

First Posted Date: 2025-05-21

Last Posted Date: 2025-05-21

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 100

Registration Number: NCT06983899

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Improving Engagement in HIV and Cancer Care in Zimbabwe

Not Applicable

Recruiting

Conditions: Cancer
HIV

First Posted Date: 2025-04-18

Last Posted Date: 2025-04-18

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 300

Registration Number: NCT06934369

Locations: 🇿🇼
Parirenyatwa Hospital, Harare, Zimbabwe

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Phase 1

Not yet recruiting

Conditions: Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
Acute Undifferentiated Leukemia
Mixed Phenotype Acute Leukemia
Recurrent Acute Undifferentiated Leukemia
Recurrent Chronic Myelomonocytic Leukemia
Recurrent Mixed Phenotype Acute Leukemia
Recurrent Myelodysplastic Syndrome
Refractory Acute Myeloid Leukemia
Refractory Myelodysplastic Syndrome

Interventions: Drug: Decitabine
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Chest Radiography
Drug: Cytarabine
Procedure: Echocardiography Test
Biological: Filgrastim
Drug: Fludarabine
Procedure: Hematopoietic Cell Transplantation
Drug: Idarubicin
Procedure: Multigated Acquisition Scan
Procedure: Pheresis
Radiation: Total-Body Irradiation
Procedure: Biospecimen Collection

First Posted Date: 2025-04-15

Last Posted Date: 2025-04-15

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 36

Registration Number: NCT06928662

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial

Not Applicable

Not yet recruiting

Conditions: Human Papillomavirus-Related Carcinoma

First Posted Date: 2025-04-13

Last Posted Date: 2025-04-13

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 1900

Registration Number: NCT06926062

Locations: 🇺🇸
Penn State University, University Park, Pennsylvania, United States
🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

Recruiting

Conditions: Financial Hardship
Alzheimer's Disease (AD)
Alzheimer's Disease and Related Dementia (ADRD)

First Posted Date: 2025-04-10

Last Posted Date: 2025-05-04

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 2460

Registration Number: NCT06922188

Locations: 🇺🇸
Fred Hutchinson Cancer Center, Seattle, Washington, United States

A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users

Not Applicable

Not yet recruiting

Conditions: Nicotine Dependence
Tobacco-Related Carcinoma

First Posted Date: 2025-04-03

Last Posted Date: 2025-04-04

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 1372

Registration Number: NCT06909500

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

Phase 2

Recruiting

Conditions: Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Recurrent Chronic Lymphocytic Leukemia
Recurrent Mantle Cell Lymphoma
Recurrent Small Lymphocytic Lymphoma
Refractory Chronic Lymphocytic Leukemia
Refractory Mantle Cell Lymphoma
Refractory Small Lymphocytic Lymphoma
Small Lymphocytic Lymphoma

Interventions: Procedure: Biospecimen Collection
Procedure: Bone Marrow Biopsy
Procedure: Computed Tomography
Procedure: Gastrointestinal Endoscopy
Biological: Rituximab
Drug: Sonrotoclax
Drug: Zanubrutinib

First Posted Date: 2025-02-21

Last Posted Date: 2025-04-25

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 20

Registration Number: NCT06839053

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Not Applicable

Not yet recruiting

Conditions: Colorectal Carcinoma

First Posted Date: 2025-02-12

Last Posted Date: 2025-03-11

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 682

Registration Number: NCT06822530

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Phase 2

Not yet recruiting

Conditions: Lymphoma
Multiple Myeloma
Respiratory Syncytial Virus Infection
Hematopoietic and Lymphatic System Neoplasm

Interventions: Drug: Remdesivir
Other: Survey Administration
Procedure: Biospecimen Collection
Procedure: Nasal Swab

First Posted Date: 2025-02-10

Last Posted Date: 2025-02-11

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 60

Registration Number: NCT06817889

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States

iCanQuit Smoking Cessation Among Hispanic Adults

Phase 3

Not yet recruiting

Conditions: Cigarette Smoking-Related Carcinoma

Interventions: Device: iCanQuit Smartphone App Smoking Cessation Program
Other: Survey Administration
Drug: Nicotine Gum
Other: Interview
Drug: Nicotine Patch
Drug: Nicotine Lozenge

First Posted Date: 2025-02-06

Last Posted Date: 2025-02-19

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 854

Registration Number: NCT06811038

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Home Terms & Conditions Privacy Policy